Author:
Neggers Jasper E.,Vercruysse Thomas,Jacquemyn Maarten,Vanstreels Els,Baloglu Erkan,Shacham Sharon,Crochiere Marsha,Landesman Yosef,Daelemans Dirk
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry
Reference51 articles.
1. BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B;Aloisi;Blood,2006
2. Chen, C., Gutierrez, M., de Nully Brown, P., Gabrail, N., Baz, R., Flinn, I., Trudel, S., Siegel, D., Mau-Sorensen, M., Reece, D., et al. (2014). Anti Tumor Activity Of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) XPO1/CRM1 Antagonist In Patients (pts) With Relapsed/Refractory Multiple Myeloma (MM) Or Waldenstrom’s Macroglobulinemia (WM). https://ash.confex.com/ash/2013/webprogram/Paper61462.html.
3. XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer;Cheng;Mol. Cancer Ther.,2014
4. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease;Cho;Nat. Biotechnol.,2013
5. Automatic and quantitative measurement of protein-protein colocalization in live cells;Costes;Biophys. J.,2004
Cited by
113 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献